about
Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?The current and future role of magnetic resonance imaging in prostate cancer detection and managementUpdates in the care and management of prostate cancer: highlights from the 2013 prostate cancer world congress, august 6-10, 2013, melbourne, australiaRole of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods.Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.Defining the level of evidence for technology adoption in the localized prostate cancer pathwayOral antibiotics in trans-rectal prostate biopsy and its efficacy to reduce infectious complications: Systematic review.The augmented prophylactic antibiotic could be more efficacious in patients undergoing transrectal prostate biopsy: a systematic review and meta-analysis.PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models.Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsyClinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy.Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trialMulticenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study.The detection and upgrade rates of prostate adenocarcinoma following transperineal template-guided prostate biopsy - a tertiary referral centre experience.Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients.Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Active surveillance for prostate cancerOutbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.Addition of Ceftriaxone and Amikacin to a Ciprofloxacin plus Metronidazole Regimen for Preventing Infectious Complications of Transrectal Ultrasound-Guided Prostate Biopsy: A Randomized Controlled Trial.Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy.Reducing infection rates after prostate biopsy.Optimization of prostate biopsy: review of technique and complications.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature.Prostate cancer: a review of active surveillance.Change in the risk stratification of prostate cancer after Slide Review by a uropathologist: the experience of a reference center for the treatment of prostate cancer.
P2860
Q26749124-B40D8019-E4BB-4F3E-BFA4-8EA005697940Q26773645-6BF7F2A0-6F32-46EB-8D15-8147A74B7198Q26864919-83802433-1236-4CAE-B9B5-040A192F0A7EQ30625083-0889C41E-378A-4630-BB8E-33FDC03E5BF1Q33166857-104B7714-D100-4ABA-B004-147754ED2ADBQ33676037-F9EDBAFB-3300-45AF-AACB-07CFC81CF526Q33779314-6FF69261-F4FB-4E6A-9E98-822ABE9F1BCEQ33890201-2933E5F6-3578-42A9-A5D4-5EE0D23BFFF4Q34041688-4E60296B-30F4-41D4-B601-D3CA691F248AQ34061419-0CA0533A-851C-47AF-B215-3B91C2A7EBDAQ34500632-0FE348D3-CDE0-428F-BE6F-14CF0E394DE6Q34525777-92786DE7-8235-4A16-B221-A2DBFCD8CE8FQ35700730-585A0F47-F222-4630-9F72-8D477A8D97D9Q35737796-EFE982D5-B3DA-4563-8D9E-A330B242058CQ36049175-8EDEC13C-FB1D-4534-BFC1-204B21B83EB5Q36071104-3A6CF346-C6B2-4ADF-AB19-66967A4D22D4Q36111875-DFDFDB38-B687-48B0-9517-A1B98F8A5CB4Q36195454-3A9E6A7A-0B05-40C1-9DCE-5787571F4EEAQ36395252-4F4BC641-7A5A-41D7-8B24-52405BA0D5EAQ36416441-664F47FF-CC09-4616-8A86-04244B1E779BQ36449942-5E053813-0997-45D8-A45B-0899208C676AQ36840690-373E4A5B-7993-43EE-896C-6C78D5A5C279Q37009160-7C36A7B8-5A8B-46C7-A955-1D84450D7597Q37029385-AD00C37E-F607-4EF9-A5BF-69D7D3217A29Q37055000-CFAE31F3-00D4-49CD-AE29-3A693C41A99DQ37060938-70826CDE-F80D-4358-B6A1-CA0F7CBD72A3Q37138594-6A756EE7-07E2-4821-866A-3F463CB580A5Q37169819-6E89B2BA-7A45-4735-AC2B-E73AC6302341Q37191405-390F4936-FA5D-4921-8503-E4025B559FE8Q37225603-D17192E5-E419-4078-9F3E-961830FBF513Q37280666-DC098255-BD1F-410D-8459-8E97716CB7A1Q37395990-0C703DF8-D65D-40EE-90BE-8FC9B5DBDF38Q37601836-208EBE79-C174-48FC-B5B9-6B9B1F87AFACQ37642109-EED8DC6E-0D8B-4300-906E-6DD174D0A693Q38178006-4A7B457B-0939-43F7-9E85-35164998044CQ38203986-4C210A77-DD3B-4655-A3F3-649767A8BB61Q38211603-DF432505-F621-40B9-A3F4-F8A6B1F14D44Q38222664-B5393C0C-E4B2-45E7-B723-ABDFFE2A8825Q38247297-0748E1F3-5FDA-4439-AB67-8DA1B47822AFQ38253942-94693EC5-AE1C-4C1D-A8AD-E3FF7CB5EAAA
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Systematic review of complications of prostate biopsy
@ast
Systematic review of complications of prostate biopsy
@en
Systematic review of complications of prostate biopsy
@nl
type
label
Systematic review of complications of prostate biopsy
@ast
Systematic review of complications of prostate biopsy
@en
Systematic review of complications of prostate biopsy
@nl
prefLabel
Systematic review of complications of prostate biopsy
@ast
Systematic review of complications of prostate biopsy
@en
Systematic review of complications of prostate biopsy
@nl
P2093
P3181
P1433
P1476
Systematic review of complications of prostate biopsy
@en
P2093
Annelies Vellekoop
Derek J. Rosario
Hashim U. Ahmed
James Catto
Robert Nam
Stacy Loeb
Vincenzo Scattoni
P304
P3181
P356
10.1016/J.EURURO.2013.05.049
P407
P577
2013-12-01T00:00:00Z